Ifp Advisors, Inc Halozyme Therapeutics, Inc. Transaction History

Ifp Advisors, Inc

$2.42 Billion
Q2 2024

A detailed history of Ifp Advisors, Inc transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Ifp Advisors, Inc holds 2,027 shares of HALO stock, worth $95,593. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,027

Previous 27 7407.41%

Holding current value

$95,593

Previous $1,000 10500.0%

% of portfolio

0.0%

Previous 0.0%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 30, 2024	BUY	$37.81 - $52.4 $75,620 - $104,800	2,000 Added 7407.41%	2,027 $106,000
Q1 2024 Jul 30, 2024	BUY	$33.68 - $41.95 $909 - $1,132	27 New	27 $1,000
Q2 2023 Aug 04, 2023	SELL	$30.28 - $38.74 $15,200 - $19,447	-502 Reduced 95.62%	23 $0
Q1 2023 Apr 18, 2023	BUY	$32.86 - $55.7 $690 - $1,169	21 Added 4.17%	525 $20,000
Q4 2022 Feb 07, 2023	SELL	$40.06 - $59.44 $48,592 - $72,100	-1,213 Reduced 70.65%	504 $13,000
Q3 2022 Nov 08, 2022	BUY	$38.53 - $51.78 $30,939 - $41,579	803 Added 87.86%	1,717 $38,000
Q2 2022 Sep 06, 2022	BUY	$37.35 - $48.3 $34,137 - $44,146	914 New	914 $18,000
Q2 2022 Aug 12, 2022	SELL	$37.35 - $48.3 $34,137 - $44,146	-914 Closed	0 $0
Q1 2022 Sep 06, 2022	BUY	$31.97 - $41.06 $28,325 - $36,379	886 Added 3164.29%	914 $36,000
Q4 2021 Jan 12, 2022	SELL	$31.82 - $40.75 $58,453 - $74,857	-1,837 Reduced 98.5%	28 $1,000
Q3 2021 Oct 06, 2021	SELL	$38.47 - $46.42 $2,192 - $2,645	-57 Reduced 2.97%	1,865 $78,000
Q2 2021 Jul 13, 2021	SELL	$38.84 - $51.31 $39,616 - $52,336	-1,020 Reduced 34.67%	1,922 $88,000
Q1 2021 Apr 30, 2021	BUY	$39.51 - $51.45 $24,417 - $31,796	618 Added 26.59%	2,942 $123,000
Q4 2020 Jan 25, 2021	BUY	$25.81 - $43.62 $59,982 - $101,372	2,324 New	2,324 $100,000
Q3 2020 Oct 29, 2020	BUY	$25.74 - $29.63 $0 - $0	0 New	0 $0
Q2 2020 Aug 05, 2020	BUY	$16.25 - $26.81 $0 - $0	0 New	0 $0
Q1 2020 May 12, 2020	BUY	$13.9 - $21.83 $0 - $0	0 New	0 $0
Q4 2019 Jan 17, 2020	BUY	$14.93 - $19.53 $0 - $0	0 New	0 $0
Q3 2019 Nov 07, 2019	BUY	$15.2 - $17.69 $0 - $0	0 New	0 $0
Q1 2019 May 15, 2019	SELL	$13.94 - $17.58 $128,596 - $162,175	-9,225 Closed	0 $0
Q4 2018 Jan 23, 2019	SELL	$13.33 - $18.66 $27,659 - $38,719	-2,075 Reduced 18.36%	9,225 $134,000
Q3 2018 Oct 25, 2018	BUY	$16.68 - $18.41 $3,753 - $4,142	225 Added 2.03%	11,300 $0
Q2 2018 Aug 07, 2018	SELL	$16.87 - $20.3 $38,801 - $46,690	-2,300 Reduced 17.2%	11,075 $0
Q1 2018 Jun 03, 2019	BUY	$17.06 - $21.2 $22,178 - $27,560	1,300 Added 10.77%	13,375 $271,000
Q1 2018 May 09, 2018	SELL	$17.06 - $21.2 $22,178 - $27,560	-1,300 Reduced 9.72%	12,075 $0
Q4 2017 Jan 24, 2018	BUY	$16.75 - $20.8 $29,128 - $36,171	1,739 Added 14.94%	13,375 $0
Q3 2017 Oct 30, 2017	SELL	$11.76 - $17.4 $35,868 - $53,069	-3,050 Reduced 20.77%	11,636 $202,000
Q2 2017 Jun 03, 2019	BUY	N/A	1,226 Added 9.11%	14,686 $188,000
Q1 2017 Jun 03, 2019	BUY	N/A	2,850 Added 26.86%	13,460 $174,000
Q4 2016 Jun 03, 2019	SELL	N/A	-467 Reduced 4.22%	10,610 $105,000
Q2 2016 Jun 03, 2019	BUY	N/A	11,077	11,077 $96,000

Others Institutions Holding HALO

# of Institutions

543

Shares Held

125M

Call Options Held

294K

Put Options Held

180K

View Full List

About HALOZYME THERAPEUTICS, INC.

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $6.57B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

More about HALO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ifp Advisors, Inc with notifications on news.

Account